Hosted on MSN1y
What to Expect From Eye Injections for AMD
how to minimize injection-related anxiety, and more. How Different Types of Eye Injections for AMD Work Syfovre, Izervay, anti-VEGF agents, steroids, and medications to keep infections in check ...
pharmaphorum4d
Apellis breaks new ground in geographic atrophy
The US regulator has cleared the company’s complement C3 inhibitor pegcetacoplan as an intravitreal injection called Syfovre for GA, which affects more than 5 million people worldwide ...
Business Insider1mon
Apellis Receives Approval of SYFOVRE® (pegcetacoplan) in Australia for Geographic Atrophy (GA)
The results were published in The Lancet in October 2023. About SYFOVRE ® (pegcetacoplan injection) SYFOVRE ® (pegcetacoplan injection) is the first-ever approved therapy for geographic atrophy ...
Nasdaq1mon
Apellis Pharmaceuticals Reports $709 Million in Preliminary Full-Year 2024 U.S. Net Product Revenues, Highlights Strategic Growth Initiatives
(pegcetacoplan injection) is the first-ever approved therapy for geographic atrophy (GA). By targeting C3, SYFOVRE is designed to provide comprehensive control of the complement cascade ...
Yahoo Finance1mon
Apellis Receives Approval of SYFOVRE® (pegcetacoplan) in Australia for Geographic Atrophy (GA)
WALTHAM, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Therapeutic Goods Administration (TGA) has approved SYFOVRE ...
Finanznachrichten29d
Apellis Pharmaceuticals, Inc.: Apellis Receives Approval of SYFOVRE (pegcetacoplan) in Australia for Geographic Atrophy (GA)
The results were published in The Lancet in October 2023. About SYFOVRE ® (pegcetacoplan injection) SYFOVRE ® (pegcetacoplan injection) is the first-ever approved therapy for geographic atrophy ...